134 related articles for article (PubMed ID: 37779528)
1. Reduced toxicity conditioning and a high CD34
Pandrowala A; Sharma AN; Kakunje M; Bodhanwala M; Hiwarkar P
J Allergy Clin Immunol Glob; 2023 Aug; 2(3):100106. PubMed ID: 37779528
[TBL] [Abstract][Full Text] [Related]
2. Hematopoietic stem cell transplantation outcomes for 11 patients with dedicator of cytokinesis 8 deficiency.
Al-Herz W; Chu JI; van der Spek J; Raghupathy R; Massaad MJ; Keles S; Biggs CM; Cockerton L; Chou J; Dbaibo G; Elisofon SA; Hanna-Wakim R; Kim HB; Lehmann LE; McDonald DR; Notarangelo LD; Veys P; Chatila TA; Geha RS; Gaspar HB; Pai SY
J Allergy Clin Immunol; 2016 Sep; 138(3):852-859.e3. PubMed ID: 27130861
[TBL] [Abstract][Full Text] [Related]
3. Lineage-Specific Chimerism and Outcome After Hematopoietic Stem Cell Transplantation for DOCK8 Deficiency.
Raedler J; Magg T; Rohlfs M; Klein C; Vallée T; Hauck F; Albert MH
J Clin Immunol; 2021 Oct; 41(7):1536-1548. PubMed ID: 34080085
[TBL] [Abstract][Full Text] [Related]
4. Hematopoietic Stem Cell Transplantation as Treatment for Patients with DOCK8 Deficiency.
Aydin SE; Freeman AF; Al-Herz W; Al-Mousa HA; Arnaout RK; Aydin RC; Barlogis V; Belohradsky BH; Bonfim C; Bredius RG; Chu JI; Ciocarlie OC; Doğu F; Gaspar HB; Geha RS; Gennery AR; Hauck F; Hawwari A; Hickstein DD; Hoenig M; Ikinciogullari A; Klein C; Kumar A; Ifversen MRS; Matthes S; Metin A; Neven B; Pai SY; Parikh SH; Picard C; Renner ED; Sanal Ö; Schulz AS; Schuster F; Shah NN; Shereck EB; Slatter MA; Su HC; van Montfrans J; Woessmann W; Ziegler JB; Albert MH;
J Allergy Clin Immunol Pract; 2019 Mar; 7(3):848-855. PubMed ID: 30391550
[TBL] [Abstract][Full Text] [Related]
5. Post-Transplant CD34
Chandra S; Bleesing JJ; Jordan MB; Grimley MS; Khandelwal P; Davies SM; Edwards S; Leemhuis T; Marsh RA
Biol Blood Marrow Transplant; 2018 Jul; 24(7):1527-1529. PubMed ID: 29555312
[TBL] [Abstract][Full Text] [Related]
6. Clinical and immunological correction of DOCK8 deficiency by allogeneic hematopoietic stem cell transplantation following a reduced toxicity conditioning regimen.
Boztug H; Karitnig-Weiß C; Ausserer B; Renner ED; Albert MH; Sawalle-Belohradsky J; Belohradsky BH; Mann G; Horcher E; Rümmele-Waibel A; Geyeregger R; Lakatos K; Peters C; Lawitschka A; Matthes-Martin S
Pediatr Hematol Oncol; 2012 Oct; 29(7):585-94. PubMed ID: 22897717
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic hematopoietic stem-cell transplantation for leukocyte adhesion deficiency.
Qasim W; Cavazzana-Calvo M; Davies EG; Davis J; Duval M; Eames G; Farinha N; Filopovich A; Fischer A; Friedrich W; Gennery A; Heilmann C; Landais P; Horwitz M; Porta F; Sedlacek P; Seger R; Slatter M; Teague L; Eapen M; Veys P
Pediatrics; 2009 Mar; 123(3):836-40. PubMed ID: 19255011
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Outcomes of Hematopoietic Stem Cell Transplantation for ZAP70 Deficiency.
Cuvelier GD; Rubin TS; Wall DA; Schroeder ML
J Clin Immunol; 2016 Oct; 36(7):713-24. PubMed ID: 27438785
[TBL] [Abstract][Full Text] [Related]
9. Tandem Orthotopic Living Donor Liver Transplantation Followed by Same Donor Haploidentical Hematopoietic Stem Cell Transplantation for DOCK8 Deficiency.
Freeman AF; Yazigi N; Shah NN; Kleiner DE; Parta M; Atkinson P; Heller T; Holland SM; Kaufman SS; Khan KM; Hickstein DD
Transplantation; 2019 Oct; 103(10):2144-2149. PubMed ID: 30720689
[TBL] [Abstract][Full Text] [Related]
10. Haploidentical peripheral blood and marrow stem cell transplantation in nine cases of primary immunodeficiency.
Lanfranchi A; Verardi R; Tettoni K; Neva A; Mazzolari E; Pennacchio M; Pasic S; Ugazio AG; Albertini A; Porta F
Haematologica; 2000 Nov; 85(11 Suppl):41-6. PubMed ID: 11268323
[TBL] [Abstract][Full Text] [Related]
11. Clinical, immunological features and follow up of 20 patients with dedicator of cytokinesis 8 (DOCK8) deficiency.
Haskologlu S; Kostel Bal S; Islamoglu C; Aytekin C; Guner S; Sevinc S; Keles S; Kendirli T; Ceylaner S; Dogu F; Ikinciogullari A
Pediatr Allergy Immunol; 2020 Jul; 31(5):515-527. PubMed ID: 32108967
[TBL] [Abstract][Full Text] [Related]
12. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
13. Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype.
Hsieh MM; Fitzhugh CD; Weitzel RP; Link ME; Coles WA; Zhao X; Rodgers GP; Powell JD; Tisdale JF
JAMA; 2014 Jul; 312(1):48-56. PubMed ID: 25058217
[TBL] [Abstract][Full Text] [Related]
14. Frequency and Risk Factors Associated with Cord Graft Failure after Transplant with Single-Unit Umbilical Cord Cells Supplemented by Haploidentical Cells with Reduced-Intensity Conditioning.
Tsai SB; Liu H; Shore T; Fan Y; Bishop M; Cushing MM; Gergis U; Godley L; Kline J; Larson RA; Martinez G; Mayer S; Odenike O; Stock W; Wickrema A; van Besien K; Artz AS
Biol Blood Marrow Transplant; 2016 Jun; 22(6):1065-1072. PubMed ID: 26912055
[TBL] [Abstract][Full Text] [Related]
15. Matched related and unrelated donor hematopoietic stem cell transplantation for DOCK8 deficiency.
Cuellar-Rodriguez J; Freeman AF; Grossman J; Su H; Parta M; Murdock H; Shah N; Bollard C; Kong HH; Moutsopoulos N; Stone K; Gea-Banacloche J; Holland SM; Hickstein DD
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1037-45. PubMed ID: 25636378
[TBL] [Abstract][Full Text] [Related]
16. Repeated CD45RA-depleted DLI successfully increases donor chimerism in a patient with beta-thalassemia major after haploidentical stem cell transplant.
Chan WYK; Kwok JSY; Chiang AKS; Chan GCF; Lee PPW; Ha SY; Cheuk DKL
Pediatr Transplant; 2021 Aug; 25(5):e13945. PubMed ID: 33314508
[TBL] [Abstract][Full Text] [Related]
17. BEAM-Campath Allogeneic Stem Cell Transplant for Patients with Relapsed/Refractory Lymphoma: High Incidence of Long-Term Mixed Donor-Recipient Chimerism and the Response to Donor Lymphocyte Infusions.
Burney C; Wadhera K; Breslin P; Pearce R; Wells M; Alajangi R; Protheroe R; Marks DI; Griffin J; Robinson S
Biol Blood Marrow Transplant; 2020 Dec; 26(12):2271-2278. PubMed ID: 32890747
[TBL] [Abstract][Full Text] [Related]
18. Reduced-intensity conditioning hematopoietic cell transplantation is an effective treatment for patients with SLAM-associated protein deficiency/X-linked lymphoproliferative disease type 1.
Marsh RA; Bleesing JJ; Chandrakasan S; Jordan MB; Davies SM; Filipovich AH
Biol Blood Marrow Transplant; 2014 Oct; 20(10):1641-5. PubMed ID: 24923536
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic hematopoietic stem cell and liver transplantation in a young girl with dedicator of cytokinesis 8 protein deficiency.
Kuloglu Z; Balcı D; Haskoloğlu ZŞ; Kendirli T; Bingöl-Koloğlu M; Tuna-Kırsaçlıoğlu C; Bal S; Selbuz S; Kırımker O; Savaş B; Altuntaş C; Güner ŞN; Can ÖS; Karayalçın K; Doğu F; Kansu Tanca A; İkincioğulları A
Pediatr Transplant; 2019 Nov; 23(7):e13545. PubMed ID: 31297914
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of DOCK8 deficiency by allogeneic hematopoietic cell transplantation from alternative donors.
Kono A; Wakamatsu M; Umezawa Y; Muramatsu H; Fujiwara H; Tomomasa D; Inoue K; Hattori K; Mitsui T; Takada H; Minegishi Y; Takahashi Y; Yamamoto M; Mori T; Kanegane H
Int J Hematol; 2023 Oct; 118(4):519-525. PubMed ID: 37131080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
